(Adds Outlook, stock movement)
For the full-year 2025, Surgery Partners, Inc. (SGRY) expects an increase in revenue from the prior year.
For the 12-mponth period, the company expects adjusted EBITDA of $555 to $565 million. Annual revenue is anticipated to be in the range of $3.30 to $3.45 billion, compared with analysts' forecast of $3.39 billion. For the full-year 2024, Surgery Partners has recorded adjusted EBITDA of $508.2 million, on revenue of $3.1 billion.
As of this writing, SGRY is up 3.82 percent at $25 in the pre-market trade on the Nasdaq.
Q4 Result:
Below are the earnings highlights for Surgery Partners.
Earnings: -$108.5 million in Q4 vs. -$1.0 million in the same period last year. EPS: -$0.86 in Q4 vs. -$0.01 in the same period last year. Excluding items, Surgery Partners reported adjusted earnings of $55.7 million or $0.44 per share for the period.
Analysts projected $0.38 per share Revenue: $864.4 million in Q4 vs. $735.4 million in the same period last year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.